ArticleCNS neuroscience & therapeutics2026
Association Between Renal Dysfunction and Cerebral Small Vessel Disease: A Prospective Cohort Study From the UK Biobank.
Article in CNS neuroscience & therapeutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
aimsThis study aims to test the association between multidimensional renal dysfunction biomarkers and cerebral small vessel disease (CSVD) risk using data from the UK Biobank.
methodsThe present study encompasses two cohorts. The whole cohort consisted of 43,314 adults without neurological diseases at baseline, who underwent brain magnetic resonance imaging (MRI) during the follow-up period. CSVD imaging markers, including white matter hyperintensity (WMH) volume, mean diffusivity (MD), and fractional anisotropy (FA), were extracted. The sub-cohort consisted of 9786 adults randomly selected from the whole cohort. CSVD MRI features, including the presence of lacunes, white matter hyperintensities (WMHs), enlarged perivascular spaces (EPVS), and cerebral microbleeds (CMBs), as well as CSVD burden score, were assessed.
resultsIn the whole cohort, renal dysfunction as reflected by abnormalities in estimated glomerular filtration rates and blood urea nitrogen was associated with increased WMH and MD values and decreased FA values, compared to the healthy group. We observed consistent findings in the sub-cohort: multidimensional renal dysfunction was associated with increased risk of lacunes, WMHs, EPVS, and CMBs, as well as greater severity of CSVD burden.
conclusionsOur large-scale epidemiological study provides evidence that multidimensional renal dysfunction biomarkers are independently associated with CSVD risk in adults.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.